Melinda Telli, MD
Melinda Telli, MD, is a medical oncologist and assistant professor of medicine in the division of medical oncology at Stanford University School of Medicine. She focuses her clinical work and research on breast cancer.
Dr. Telli's primary research focus is the development of new therapeutic strategies for the treatment of early-stage, triple-negative and BRCA1/2 mutation-associated breast cancer. She is interested in studies in early breast cancer that incorporate predictive biomarkers of response to therapy and their translation into clinical care. Her other interests include the impact of anti-cancer therapies on the heart.
Dr. Telli is the recipient of a Susan G. Komen for the Cure Translational Postdoctoral Fellowship Award (2008), American Society of Clinical Oncology Young Investigator Award (2009), and Susan G. Komen for the Cure Career Catalyst Research Award (2012).